Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
without form-deprivation amblyopia
optical correction of any refractive error
For mild to moderate strabismic and/or anisometropic amblyopia, first-line treatment is with optical correction alone.[51]Chen PL, Chen JT, Tai MC, et al. Anisometropic amblyopia treated with spectacle correction alone: possible factors predicting success and time to start patching. Am J Ophthalmol. 2007 Jan;143(1):54-60. http://www.ncbi.nlm.nih.gov/pubmed/17113556?tool=bestpractice.com [52]Cotter SA, Edwards AR, Wallace DK, et al. Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology. 2006 Jun;113(6):895-903. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1790727 http://www.ncbi.nlm.nih.gov/pubmed/16751032?tool=bestpractice.com
Guidelines for prescribing spectacles to treat amblyopia in young children depend on patient age and other risk factors.[1]American Academy of Ophthalmology. Amblyopia PPP 2022 - updated 2024. Dec 2022 [internet publication]. https://www.aao.org/education/preferred-practice-pattern/amblyopia-ppp-2022 The recommended period to achieve maximum refractive adaptation in the amblyopic eye is 18-22 weeks, but most improvement is seen by 4-12 weeks.[51]Chen PL, Chen JT, Tai MC, et al. Anisometropic amblyopia treated with spectacle correction alone: possible factors predicting success and time to start patching. Am J Ophthalmol. 2007 Jan;143(1):54-60. http://www.ncbi.nlm.nih.gov/pubmed/17113556?tool=bestpractice.com [54]Writing Committee for the Pediatric Eye Disease Investigator Group; Cotter SA, Foster NC, Holmes JM, et al. Optical treatment of strabismic and combined strabismic-anisometropic amblyopia. Ophthalmology. 2012 Jan;119(1):150-8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250558 http://www.ncbi.nlm.nih.gov/pubmed/21959371?tool=bestpractice.com
Factors associated with successful optical correction include better baseline visual acuity of the amblyopic eye, interocular difference in visual acuity, stereoacuity, and amblyopic eye spherical-equivalence refractive error.[56]Hernández-Andrés R, Luque MJ, Serrano MÁ, et al. Factors affecting the benefit of glasses alone in treating childhood amblyopia: an analysis of PEDIG data. BMC Ophthalmol. 2023 Sep 28;23(1):396. https://bmcophthalmol.biomedcentral.com/articles/10.1186/s12886-023-03116-8 http://www.ncbi.nlm.nih.gov/pubmed/37770832?tool=bestpractice.com
Extended optical correction before patching may be associated with lower treatment success. The EuPatch multicenter, randomized controlled trial found that early patching (wearing spectacles for only 3 weeks before patching) was more effective than extended optical treatment (18 weeks of optical correction before patching) for children with anisometropic, strabismic, or combined-mechanism amblyopia.[57]Proudlock FA, Hisaund M, Maconachie G, et al. Extended optical treatment versus early patching with an intensive patching regimen in children with amblyopia in Europe (EuPatch): a multicentre, randomised controlled trial. Lancet. 2024 May 4;403(10438):1766-78. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02893-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/38704172?tool=bestpractice.com Early patching was more beneficial for severe amblyopia, older children, and larger differences in refractive errors between eyes; extended optical treatment was more beneficial in younger children and mild amblyopia.[57]Proudlock FA, Hisaund M, Maconachie G, et al. Extended optical treatment versus early patching with an intensive patching regimen in children with amblyopia in Europe (EuPatch): a multicentre, randomised controlled trial. Lancet. 2024 May 4;403(10438):1766-78. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02893-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/38704172?tool=bestpractice.com
Children and parents or caregivers should be made aware of the importance of good adherence to spectacles wearing, which is often suboptimal and highly variable.[58]Maconachie GD, Farooq S, Bush G, et al. Association between adherence to glasses wearing during amblyopia treatment and improvement in visual acuity. J AMA Ophthalmol. 2016 Dec 1;134(12):1347-53. http://www.ncbi.nlm.nih.gov/pubmed/27737444?tool=bestpractice.com
Treatment for amblyopia is regarded as being less effective in children age ≥7 years.[85]West S, Williams C. Amblyopia in children (aged 7 years or less). BMJ Clin Evid. 2016 Jan 5;2016:0709. https://pmc.ncbi.nlm.nih.gov/articles/PMC4701128 http://www.ncbi.nlm.nih.gov/pubmed/26731564?tool=bestpractice.com [86]Holmes JM, Lazar EL, Melia BM, et al. Pediatric Eye Disease Investigator Group. Effect of age on response to amblyopia treatment in children. Arch Ophthalmol. 2011 Nov;129(11):1451-7. https://archopht.jamanetwork.com/article.aspx?articleid=1106477 http://www.ncbi.nlm.nih.gov/pubmed/21746970?tool=bestpractice.com There is, however, evidence to suggest that older children (ages 7-12 years) respond partially to amblyopia treatment with spectacles, atropine, and patching, and that the resultant visual benefits may be maintained for between at least 6 and 12 months.[87]Scheiman MM, Hertle RW, Beck RW, et al. Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol. 2005 Apr;123(4):437-47. https://www.doi.org/10.1001/archopht.123.4.437 http://www.ncbi.nlm.nih.gov/pubmed/15824215?tool=bestpractice.com [88]Hertle RW, Scheiman MM, Beck RW, et al; Pediatric Eye Disease Investigator Group. Stability of visual acuity improvement following discontinuation of amblyopia treatment in children aged 7 to 12 years. Arch Ophthalmol. 2007 May;125(5):655-9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2614923 http://www.ncbi.nlm.nih.gov/pubmed/17502505?tool=bestpractice.com [89]Osborne DC, Greenhalgh KM, Evans MJE, et al. Atropine penalization versus occlusion therapies for unilateral amblyopia after the critical period of visual development: a systematic review. Ophthalmol Ther. 2018 Dec;7(2):323-32. https://link.springer.com/article/10.1007/s40123-018-0151-9 http://www.ncbi.nlm.nih.gov/pubmed/30328078?tool=bestpractice.com
Following randomization to treatment with full-time patching or with daily atropine therapy, similar improvements in visual acuity (2.3 to 2.4 lines) have been reported at 6 months in patients ages 8-20 years with anisometropic amblyopia (visual acuity of 20/40 to 20/200).[91]Scheiman MM, Hertle RW, Kraker RT, et al; Pediatric Eye Disease Investigator Group. Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial. Arch Ophthalmol. 2008 Dec;126(12):1634-42. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846774 http://www.ncbi.nlm.nih.gov/pubmed/19064841?tool=bestpractice.com
The treatments do not differ for older children (at least to age 15 years), although the exact regimens may vary.[1]American Academy of Ophthalmology. Amblyopia PPP 2022 - updated 2024. Dec 2022 [internet publication]. https://www.aao.org/education/preferred-practice-pattern/amblyopia-ppp-2022
patching or atropine
Treatment recommended for SOME patients in selected patient group
If amblyopia does not resolve with spectacles alone, patching or atropine penalization are usually added after a period of refractive adaptation, during which improvements in visual acuity are allowed to plateau.[51]Chen PL, Chen JT, Tai MC, et al. Anisometropic amblyopia treated with spectacle correction alone: possible factors predicting success and time to start patching. Am J Ophthalmol. 2007 Jan;143(1):54-60. http://www.ncbi.nlm.nih.gov/pubmed/17113556?tool=bestpractice.com [52]Cotter SA, Edwards AR, Wallace DK, et al. Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology. 2006 Jun;113(6):895-903. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1790727 http://www.ncbi.nlm.nih.gov/pubmed/16751032?tool=bestpractice.com [53]Stewart CE, Moseley MJ, Fielder AR, et al; MOTAS Cooperative. Refractive adaptation in amblyopia: quantification of effect and implications for practice. Br J Ophthalmol. 2004 Dec;88(12):1552-6. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1772452 http://www.ncbi.nlm.nih.gov/pubmed/15548811?tool=bestpractice.com [54]Writing Committee for the Pediatric Eye Disease Investigator Group; Cotter SA, Foster NC, Holmes JM, et al. Optical treatment of strabismic and combined strabismic-anisometropic amblyopia. Ophthalmology. 2012 Jan;119(1):150-8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250558 http://www.ncbi.nlm.nih.gov/pubmed/21959371?tool=bestpractice.com [55]Clarke MP, Wright CM, Hrisos S, et al. Randomised controlled trial of treatment of unilateral visual impairment detected at preschool vision screening. BMJ. 2003 Nov 29;327(7426):1251. https://www.doi.org/10.1136/bmj.327.7426.1251 http://www.ncbi.nlm.nih.gov/pubmed/14644966?tool=bestpractice.com The recommended period to achieve maximum refractive adaptation in the amblyopic eye is 18-22 weeks, but most improvement is seen by 4-12 weeks.[51]Chen PL, Chen JT, Tai MC, et al. Anisometropic amblyopia treated with spectacle correction alone: possible factors predicting success and time to start patching. Am J Ophthalmol. 2007 Jan;143(1):54-60. http://www.ncbi.nlm.nih.gov/pubmed/17113556?tool=bestpractice.com [54]Writing Committee for the Pediatric Eye Disease Investigator Group; Cotter SA, Foster NC, Holmes JM, et al. Optical treatment of strabismic and combined strabismic-anisometropic amblyopia. Ophthalmology. 2012 Jan;119(1):150-8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250558 http://www.ncbi.nlm.nih.gov/pubmed/21959371?tool=bestpractice.com
Patching and atropine penalization are equally effective, and visual benefits of treatment are maintained in the long term.[68]Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2002 Mar;120(3):268-78. http://www.ncbi.nlm.nih.gov/pubmed/11879129?tool=bestpractice.com [69]Repka MX, Kraker RT, Beck RW, et al. A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years. Arch Ophthalmol. 2008 Aug;126(8):1039-44. http://www.ncbi.nlm.nih.gov/pubmed/18695096?tool=bestpractice.com Atropine has been associated with better adherence and quality of life compared with patching, but with increased risk for adverse events.[70]Li T, Qureshi R, Taylor K. Conventional occlusion versus pharmacologic penalization for amblyopia. Cochrane Database Syst Rev. 2019 Aug 28;8(8):CD006460. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006460.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/31461545?tool=bestpractice.com Patching occludes vision in the better eye, whereas atropine eye drops blur vision in the better eye.
Treatment for amblyopia is regarded as being less effective in children age ≥7 years.[85]West S, Williams C. Amblyopia in children (aged 7 years or less). BMJ Clin Evid. 2016 Jan 5;2016:0709. https://pmc.ncbi.nlm.nih.gov/articles/PMC4701128 http://www.ncbi.nlm.nih.gov/pubmed/26731564?tool=bestpractice.com [86]Holmes JM, Lazar EL, Melia BM, et al. Pediatric Eye Disease Investigator Group. Effect of age on response to amblyopia treatment in children. Arch Ophthalmol. 2011 Nov;129(11):1451-7. https://archopht.jamanetwork.com/article.aspx?articleid=1106477 http://www.ncbi.nlm.nih.gov/pubmed/21746970?tool=bestpractice.com There is, however, evidence to suggest that older children (ages 7-12 years) respond partially to amblyopia treatment with spectacles, atropine, and patching, and that the resultant visual benefits may be maintained for between at least 6 and 12 months.[87]Scheiman MM, Hertle RW, Beck RW, et al. Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol. 2005 Apr;123(4):437-47. https://www.doi.org/10.1001/archopht.123.4.437 http://www.ncbi.nlm.nih.gov/pubmed/15824215?tool=bestpractice.com [88]Hertle RW, Scheiman MM, Beck RW, et al; Pediatric Eye Disease Investigator Group. Stability of visual acuity improvement following discontinuation of amblyopia treatment in children aged 7 to 12 years. Arch Ophthalmol. 2007 May;125(5):655-9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2614923 http://www.ncbi.nlm.nih.gov/pubmed/17502505?tool=bestpractice.com [89]Osborne DC, Greenhalgh KM, Evans MJE, et al. Atropine penalization versus occlusion therapies for unilateral amblyopia after the critical period of visual development: a systematic review. Ophthalmol Ther. 2018 Dec;7(2):323-32. https://link.springer.com/article/10.1007/s40123-018-0151-9 http://www.ncbi.nlm.nih.gov/pubmed/30328078?tool=bestpractice.com
Following randomization to treatment with full-time patching or with daily atropine therapy, similar improvements in visual acuity (2.3 to 2.4 lines) have been reported at 6 months in patients ages 8-20 years with anisometropic amblyopia (visual acuity of 20/40 to 20/200).[90]Menon V, Shailesh G, Sharma P, et al. Clinical trial of patching versus atropine penalization for the treatment of anisometropic amblyopia in older children. J AAPOS. 2008 Oct;12(5):493-7. http://www.ncbi.nlm.nih.gov/pubmed/18534880?tool=bestpractice.com
The treatments do not differ for older children (at least to age 15 years), although the exact regimens may vary.[1]American Academy of Ophthalmology. Amblyopia PPP 2022 - updated 2024. Dec 2022 [internet publication]. https://www.aao.org/education/preferred-practice-pattern/amblyopia-ppp-2022
Patching should be applied directly to the periorbital skin for full occlusive therapy, as opposed to being applied to the spectacle lens (the latter allows children to look around the patch).[1]American Academy of Ophthalmology. Amblyopia PPP 2022 - updated 2024. Dec 2022 [internet publication]. https://www.aao.org/education/preferred-practice-pattern/amblyopia-ppp-2022 Over-spectacle patching may be a useful alternative for children experiencing skin irritation with adhesive patching.[59]Kim SJ, Jeon H, Jung JH, et al. Comparison between over-glasses patching and adhesive patching for children with moderate amblyopia: a prospective randomized clinical trial. Graefes Arch Clin Exp Ophthalmol. 2018 Feb;256(2):429-37. http://www.ncbi.nlm.nih.gov/pubmed/29204689?tool=bestpractice.com A dose-response relationship probably exists between patching duration and amblyopia treatment response.[60]Awan M, Proudlock FA, Gottlob I. A randomized controlled trial of unilateral strabismic and mixed amblyopia using occlusion dose monitors to record compliance. Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1435-9. https://iovs.arvojournals.org/article.aspx?articleid=2124546 http://www.ncbi.nlm.nih.gov/pubmed/15790912?tool=bestpractice.com [61]Stewart CE, Stephens DA, Fielder AR, et al. Objectively monitored patching regimens for treatment of amblyopia: randomised trial. BMJ. 2007 Oct 6;335(7622):707. https://www.bmj.com/cgi/content/full/335/7622/707 http://www.ncbi.nlm.nih.gov/pubmed/17855283?tool=bestpractice.com [62]Stewart CE, Moseley MJ, Stephens DA, et al. Treatment dose-response in amblyopia therapy: the Monitored Occlusion Treatment of Amblyopia Study (MOTAS). Invest Ophthalmol Vis Sci. 2004 Sep;45(9):3048-54. https://iovs.arvojournals.org/article.aspx?articleid=2163758 http://www.ncbi.nlm.nih.gov/pubmed/15326120?tool=bestpractice.com [63]White E, Walsh L. The impact of occlusion therapy and predictors on amblyopia dose-response relationship. Strabismus. 2022 Jun;30(2):78-89. http://www.ncbi.nlm.nih.gov/pubmed/35259060?tool=bestpractice.com
Daily treatment duration: improvement of visual acuity of the amblyopic eye (from baseline to 4 months) did not differ between children (age <7 years; with moderate amblyopia) randomized to 2 hours or to 6 hours of daily patching.[64]Repka MX, Beck RW, Holmes JM, et al; Pediatric Eye Disease Investigator Group. A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol. 2003 May;121(5):603-11. http://www.ncbi.nlm.nih.gov/pubmed/12742836?tool=bestpractice.com In another randomized study, 2 hours of daily patching was significantly superior to optical treatment alone in children with mild to severe strabismic and/or anisometropic amblyopia.[65]Wallace DK, Edwards AR, Cotter SA, et al. A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children. Ophthalmology. 2006 Jun;113(6):904-12. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1609192 http://www.ncbi.nlm.nih.gov/pubmed/16751033?tool=bestpractice.com
Dose intensity and overall treatment duration: one multicenter, randomized controlled trial reported that early intense patching (10 hours/day for 6 days/week) was more effective than extended optical treatment for shortening the treatment period, reducing the number of patching hours over time, and improving compliance.[57]Proudlock FA, Hisaund M, Maconachie G, et al. Extended optical treatment versus early patching with an intensive patching regimen in children with amblyopia in Europe (EuPatch): a multicentre, randomised controlled trial. Lancet. 2024 May 4;403(10438):1766-78. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02893-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/38704172?tool=bestpractice.com A faster treatment response may be seen in strabismic and/or severe amblyopia, in younger children, and during the first month of occlusive therapy.[63]White E, Walsh L. The impact of occlusion therapy and predictors on amblyopia dose-response relationship. Strabismus. 2022 Jun;30(2):78-89. http://www.ncbi.nlm.nih.gov/pubmed/35259060?tool=bestpractice.com
Compliance: patients are often noncompliant with patching due to adverse effects such as irritation, forced use of an eye with degraded vision, poor cosmesis, and lengthy treatment periods. Interventional materials may improve compliance in poorly adherent children and in children of non-native parents who speak the host country language poorly.[66]Tjiam AM, Holtslag G, Van Minderhout HM, et al. Randomised comparison of three tools for improving compliance with occlusion therapy: an educational cartoon story, a reward calendar, and an information leaflet for parents. Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):321-9. http://www.ncbi.nlm.nih.gov/pubmed/22820813?tool=bestpractice.com [67]Pradeep A, Proudlock FA, Awan M, et al. An educational intervention to improve adherence to high-dosage patching regimen for amblyopia: a randomised controlled trial. Br J Ophthalmol. 2014 Jul;98(7):865-70. http://www.ncbi.nlm.nih.gov/pubmed/24615684?tool=bestpractice.com Poor visual acuity at baseline has been associated with poor compliance.[60]Awan M, Proudlock FA, Gottlob I. A randomized controlled trial of unilateral strabismic and mixed amblyopia using occlusion dose monitors to record compliance. Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1435-9. https://iovs.arvojournals.org/article.aspx?articleid=2124546 http://www.ncbi.nlm.nih.gov/pubmed/15790912?tool=bestpractice.com
Atropine eye drops to blur the vision in the better eye (atropine or optical penalization therapy) are sometimes used as an alternative to patching. Patching and atropine penalization are equally effective, and visual benefits of treatment are maintained in the long term.[68]Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2002 Mar;120(3):268-78. http://www.ncbi.nlm.nih.gov/pubmed/11879129?tool=bestpractice.com [69]Repka MX, Kraker RT, Beck RW, et al. A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years. Arch Ophthalmol. 2008 Aug;126(8):1039-44. http://www.ncbi.nlm.nih.gov/pubmed/18695096?tool=bestpractice.com Atropine has been associated with better adherence and quality of life compared with patching, but with increased risk for adverse events.[70]Li T, Qureshi R, Taylor K. Conventional occlusion versus pharmacologic penalization for amblyopia. Cochrane Database Syst Rev. 2019 Aug 28;8(8):CD006460. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006460.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/31461545?tool=bestpractice.com
Children ages 3 to <7 years old with moderate amblyopia who were randomized to weekend atropine demonstrated an equivalent treatment response (improvement in visual acuity of the amblyopic eye from baseline to 4 months of 2.3 lines) to that of children receiving daily atropine.[71]Repka MX, Cotter SA, Beck RW, et al. A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology. 2004 Nov;111(11):2076-85. http://www.ncbi.nlm.nih.gov/pubmed/15522375?tool=bestpractice.com
Primary options
atropine ophthalmic: (1%) children ≥3 months of age: 1 drop into the nonamblyopic eye once daily; children ≥3 years of age: 1 drop into the nonamblyopic eye once daily, may repeat dose up to twice daily
More atropine ophthalmicDose regimens may vary (e.g., drops may be administered daily, on weekends only, or on 2 consecutive days each week). Consult your local guidelines or drug information source for more information.
plano lens in atropinized eye
Treatment recommended for SOME patients in selected patient group
A plano lens for the amblyopic eye can be added to atropine treatment. There may be a very small additional benefit of a plano lens in patients undergoing weekend atropine penalization.[72]Pediatric Eye Disease Investigator Group. Pharmacological plus optical penalization treatment for amblyopia: results of a randomized trial. Arch Ophthalmol. 2009 Jan;127(1):22-30. https://www.doi.org/10.1001/archophthalmol.2008.520 http://www.ncbi.nlm.nih.gov/pubmed/19139333?tool=bestpractice.com
management of strabismus
Treatment recommended for SOME patients in selected patient group
After the amblyopia has been treated, children with residual strabismus typically undergo strabismus surgery. See Strabismus.
optical correction of any refractive error
The correction of any refractive errors with spectacles is key in amblyopia treatment.[51]Chen PL, Chen JT, Tai MC, et al. Anisometropic amblyopia treated with spectacle correction alone: possible factors predicting success and time to start patching. Am J Ophthalmol. 2007 Jan;143(1):54-60. http://www.ncbi.nlm.nih.gov/pubmed/17113556?tool=bestpractice.com [52]Cotter SA, Edwards AR, Wallace DK, et al. Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology. 2006 Jun;113(6):895-903. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1790727 http://www.ncbi.nlm.nih.gov/pubmed/16751032?tool=bestpractice.com
Guidelines for prescribing spectacles to treat amblyopia in young children depend on patient age and other risk factors.[1]American Academy of Ophthalmology. Amblyopia PPP 2022 - updated 2024. Dec 2022 [internet publication]. https://www.aao.org/education/preferred-practice-pattern/amblyopia-ppp-2022 The recommended period to achieve maximum refractive adaptation in the amblyopic eye is 18-22 weeks, but most improvement is seen by 4-12 weeks.[51]Chen PL, Chen JT, Tai MC, et al. Anisometropic amblyopia treated with spectacle correction alone: possible factors predicting success and time to start patching. Am J Ophthalmol. 2007 Jan;143(1):54-60. http://www.ncbi.nlm.nih.gov/pubmed/17113556?tool=bestpractice.com [54]Writing Committee for the Pediatric Eye Disease Investigator Group; Cotter SA, Foster NC, Holmes JM, et al. Optical treatment of strabismic and combined strabismic-anisometropic amblyopia. Ophthalmology. 2012 Jan;119(1):150-8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250558 http://www.ncbi.nlm.nih.gov/pubmed/21959371?tool=bestpractice.com
Factors associated with successful optical correction include better baseline visual acuity of the amblyopic eye, interocular difference in visual acuity, stereoacuity, and amblyopic eye spherical-equivalence refractive error.[56]Hernández-Andrés R, Luque MJ, Serrano MÁ, et al. Factors affecting the benefit of glasses alone in treating childhood amblyopia: an analysis of PEDIG data. BMC Ophthalmol. 2023 Sep 28;23(1):396. https://bmcophthalmol.biomedcentral.com/articles/10.1186/s12886-023-03116-8 http://www.ncbi.nlm.nih.gov/pubmed/37770832?tool=bestpractice.com
Extended optical correction before patching may be associated with lower treatment success. The EuPatch multicenter, randomized controlled trial found that early patching (wearing spectacles for only 3 weeks before patching) was more effective than extended optical treatment (18 weeks of optical correction before patching) for children with anisometropic, strabismic, or combined-mechanism amblyopia.[57]Proudlock FA, Hisaund M, Maconachie G, et al. Extended optical treatment versus early patching with an intensive patching regimen in children with amblyopia in Europe (EuPatch): a multicentre, randomised controlled trial. Lancet. 2024 May 4;403(10438):1766-78. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02893-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/38704172?tool=bestpractice.com Early patching was more beneficial for severe amblyopia, older children, and larger differences in refractive errors between eyes; extended optical treatment was more beneficial in younger children and mild amblyopia.[57]Proudlock FA, Hisaund M, Maconachie G, et al. Extended optical treatment versus early patching with an intensive patching regimen in children with amblyopia in Europe (EuPatch): a multicentre, randomised controlled trial. Lancet. 2024 May 4;403(10438):1766-78. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02893-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/38704172?tool=bestpractice.com
Children and parents or caregivers should be made aware of the importance of good adherence to spectacles wearing, which is often suboptimal and highly variable.[58]Maconachie GD, Farooq S, Bush G, et al. Association between adherence to glasses wearing during amblyopia treatment and improvement in visual acuity. J AMA Ophthalmol. 2016 Dec 1;134(12):1347-53. http://www.ncbi.nlm.nih.gov/pubmed/27737444?tool=bestpractice.com
Treatment for amblyopia is regarded as being less effective in children age ≥7 years.[85]West S, Williams C. Amblyopia in children (aged 7 years or less). BMJ Clin Evid. 2016 Jan 5;2016:0709. https://pmc.ncbi.nlm.nih.gov/articles/PMC4701128 http://www.ncbi.nlm.nih.gov/pubmed/26731564?tool=bestpractice.com [86]Holmes JM, Lazar EL, Melia BM, et al. Pediatric Eye Disease Investigator Group. Effect of age on response to amblyopia treatment in children. Arch Ophthalmol. 2011 Nov;129(11):1451-7. https://archopht.jamanetwork.com/article.aspx?articleid=1106477 http://www.ncbi.nlm.nih.gov/pubmed/21746970?tool=bestpractice.com There is, however, evidence to suggest that older children (ages 7-12 years) respond partially to amblyopia treatment with spectacles, atropine, and patching, and that the resultant visual benefits may be maintained for between at least 6 and 12 months.[87]Scheiman MM, Hertle RW, Beck RW, et al. Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol. 2005 Apr;123(4):437-47. https://www.doi.org/10.1001/archopht.123.4.437 http://www.ncbi.nlm.nih.gov/pubmed/15824215?tool=bestpractice.com [88]Hertle RW, Scheiman MM, Beck RW, et al; Pediatric Eye Disease Investigator Group. Stability of visual acuity improvement following discontinuation of amblyopia treatment in children aged 7 to 12 years. Arch Ophthalmol. 2007 May;125(5):655-9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2614923 http://www.ncbi.nlm.nih.gov/pubmed/17502505?tool=bestpractice.com [89]Osborne DC, Greenhalgh KM, Evans MJE, et al. Atropine penalization versus occlusion therapies for unilateral amblyopia after the critical period of visual development: a systematic review. Ophthalmol Ther. 2018 Dec;7(2):323-32. https://link.springer.com/article/10.1007/s40123-018-0151-9 http://www.ncbi.nlm.nih.gov/pubmed/30328078?tool=bestpractice.com
Following randomization to treatment with full-time patching or with daily atropine therapy, similar improvements in visual acuity (2.3 to 2.4 lines) have been reported at 6 months in patients ages 8-20 years with anisometropic amblyopia (visual acuity of 20/40 to 20/200).[90]Menon V, Shailesh G, Sharma P, et al. Clinical trial of patching versus atropine penalization for the treatment of anisometropic amblyopia in older children. J AAPOS. 2008 Oct;12(5):493-7. http://www.ncbi.nlm.nih.gov/pubmed/18534880?tool=bestpractice.com
The treatments do not differ for older children (at least to age 15 years), although the exact regimens may vary.[1]American Academy of Ophthalmology. Amblyopia PPP 2022 - updated 2024. Dec 2022 [internet publication]. https://www.aao.org/education/preferred-practice-pattern/amblyopia-ppp-2022
patching or consideration of atropine
Treatment recommended for ALL patients in selected patient group
Children with severe strabismic and/or anisometropic amblyopia require optical correction of refractive errors and additional treatment with patching or optical penalization.[51]Chen PL, Chen JT, Tai MC, et al. Anisometropic amblyopia treated with spectacle correction alone: possible factors predicting success and time to start patching. Am J Ophthalmol. 2007 Jan;143(1):54-60. http://www.ncbi.nlm.nih.gov/pubmed/17113556?tool=bestpractice.com [52]Cotter SA, Edwards AR, Wallace DK, et al. Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology. 2006 Jun;113(6):895-903. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1790727 http://www.ncbi.nlm.nih.gov/pubmed/16751032?tool=bestpractice.com Patching is the standard addition, although evidence suggests that atropine is also effective.[74]Repka MX, Kraker RT, Beck RW, et al; Pediatric Eye Disease Investigator Group. Treatment of severe amblyopia with weekend atropine: results from two randomized clinical trials. J AAPOS. 2009 Jun;13(3):258-63. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713117 http://www.ncbi.nlm.nih.gov/pubmed/19541265?tool=bestpractice.com
Adding patching to spectacles, after visual acuity has stabilized with spectacles alone, is beneficial in this group.[65]Wallace DK, Edwards AR, Cotter SA, et al. A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children. Ophthalmology. 2006 Jun;113(6):904-12. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1609192 http://www.ncbi.nlm.nih.gov/pubmed/16751033?tool=bestpractice.com Patching for 6 hours daily has been found to be equally effective to patching full time.[75]Holmes JM, Kraker RT, Beck RW, et al; Pediatric Eye Disease Investigator Group. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology. 2003 Nov;110(11):2075-87. http://www.ncbi.nlm.nih.gov/pubmed/14597512?tool=bestpractice.com
Compliance with patching needs to be taken into consideration. Patching for 2 hours daily improves visual acuity in severe amblyopia, although the magnitude of improvement may be less than with more robust patching regimens.[76]Pediatric Eye Disease Investigator Group. A randomized trial of near versus distance activities while patching for amblyopia in children aged 3 to less than 7 years. Ophthalmology. 2008 Nov;115(11):2071-8. http://www.ncbi.nlm.nih.gov/pubmed/18789533?tool=bestpractice.com The EuPatch study found that early patching with an intensive starting dose of 10 hours per day (for 6 days a week) was beneficial in most children with severe amblyopia.[57]Proudlock FA, Hisaund M, Maconachie G, et al. Extended optical treatment versus early patching with an intensive patching regimen in children with amblyopia in Europe (EuPatch): a multicentre, randomised controlled trial. Lancet. 2024 May 4;403(10438):1766-78. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02893-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/38704172?tool=bestpractice.com With improved visual acuity, the prescribed number of patching hours decreased significantly over the course of the trial.
Some clinicians may intensify treatment by adding topical atropine to the daily patching regiment, but the literature suggests minimal to no added benefit with this approach.[77]Wang S, Wen W, Zhu W, et al. Effect of combined atropine and patching vs patching alone for treatment of severe amblyopia in children aged 3 to 12 years: a randomized clinical trial. JAMA Ophthalmol. 2021 Sep 1;139(9):990-6. https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2781899 http://www.ncbi.nlm.nih.gov/pubmed/34264296?tool=bestpractice.com [78]Pediatric Eye Disease Investigator Group (PEDIG) Writing Committee; Wallace DK, Kraker RT, Beck RW, et al. Randomized trial to evaluate combined patching and atropine for residual amblyopia. Arch Ophthalmol. 2011 Jul;129(7):960-2. https://pmc.ncbi.nlm.nih.gov/articles/PMC3156057 http://www.ncbi.nlm.nih.gov/pubmed/21746992?tool=bestpractice.com
Treatment for amblyopia is regarded as being less effective in children age ≥7 years.[85]West S, Williams C. Amblyopia in children (aged 7 years or less). BMJ Clin Evid. 2016 Jan 5;2016:0709. https://pmc.ncbi.nlm.nih.gov/articles/PMC4701128 http://www.ncbi.nlm.nih.gov/pubmed/26731564?tool=bestpractice.com [86]Holmes JM, Lazar EL, Melia BM, et al. Pediatric Eye Disease Investigator Group. Effect of age on response to amblyopia treatment in children. Arch Ophthalmol. 2011 Nov;129(11):1451-7. https://archopht.jamanetwork.com/article.aspx?articleid=1106477 http://www.ncbi.nlm.nih.gov/pubmed/21746970?tool=bestpractice.com There is, however, evidence to suggest that older children (ages 7-12 years) respond partially to amblyopia treatment with spectacles, atropine, and patching, and that the resultant visual benefits may be maintained for between at least 6 and 12 months.[87]Scheiman MM, Hertle RW, Beck RW, et al. Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol. 2005 Apr;123(4):437-47. https://www.doi.org/10.1001/archopht.123.4.437 http://www.ncbi.nlm.nih.gov/pubmed/15824215?tool=bestpractice.com [88]Hertle RW, Scheiman MM, Beck RW, et al; Pediatric Eye Disease Investigator Group. Stability of visual acuity improvement following discontinuation of amblyopia treatment in children aged 7 to 12 years. Arch Ophthalmol. 2007 May;125(5):655-9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2614923 http://www.ncbi.nlm.nih.gov/pubmed/17502505?tool=bestpractice.com [89]Osborne DC, Greenhalgh KM, Evans MJE, et al. Atropine penalization versus occlusion therapies for unilateral amblyopia after the critical period of visual development: a systematic review. Ophthalmol Ther. 2018 Dec;7(2):323-32. https://link.springer.com/article/10.1007/s40123-018-0151-9 http://www.ncbi.nlm.nih.gov/pubmed/30328078?tool=bestpractice.com
Following randomization to treatment with full-time patching or with daily atropine therapy, similar improvements in visual acuity (2.3 to 2.4 lines) have been reported at 6 months in patients ages 8-20 years with anisometropic amblyopia (visual acuity of 20/40 to 20/200).[90]Menon V, Shailesh G, Sharma P, et al. Clinical trial of patching versus atropine penalization for the treatment of anisometropic amblyopia in older children. J AAPOS. 2008 Oct;12(5):493-7. http://www.ncbi.nlm.nih.gov/pubmed/18534880?tool=bestpractice.com
The treatments do not differ for older children (at least to age 15 years), although the exact regimens may vary.[1]American Academy of Ophthalmology. Amblyopia PPP 2022 - updated 2024. Dec 2022 [internet publication]. https://www.aao.org/education/preferred-practice-pattern/amblyopia-ppp-2022
Patching should be applied directly to the periorbital skin for full occlusive therapy, as opposed to being applied to the spectacle lens (the latter allows children to look around the patch).[1]American Academy of Ophthalmology. Amblyopia PPP 2022 - updated 2024. Dec 2022 [internet publication]. https://www.aao.org/education/preferred-practice-pattern/amblyopia-ppp-2022 However, over-spectacle patching may be a useful alternative for children experiencing skin irritation with adhesive patching.[59]Kim SJ, Jeon H, Jung JH, et al. Comparison between over-glasses patching and adhesive patching for children with moderate amblyopia: a prospective randomized clinical trial. Graefes Arch Clin Exp Ophthalmol. 2018 Feb;256(2):429-37. http://www.ncbi.nlm.nih.gov/pubmed/29204689?tool=bestpractice.com A dose-response relationship probably exists between patching duration and amblyopia treatment response.[60]Awan M, Proudlock FA, Gottlob I. A randomized controlled trial of unilateral strabismic and mixed amblyopia using occlusion dose monitors to record compliance. Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1435-9. https://iovs.arvojournals.org/article.aspx?articleid=2124546 http://www.ncbi.nlm.nih.gov/pubmed/15790912?tool=bestpractice.com [61]Stewart CE, Stephens DA, Fielder AR, et al. Objectively monitored patching regimens for treatment of amblyopia: randomised trial. BMJ. 2007 Oct 6;335(7622):707. https://www.bmj.com/cgi/content/full/335/7622/707 http://www.ncbi.nlm.nih.gov/pubmed/17855283?tool=bestpractice.com [62]Stewart CE, Moseley MJ, Stephens DA, et al. Treatment dose-response in amblyopia therapy: the Monitored Occlusion Treatment of Amblyopia Study (MOTAS). Invest Ophthalmol Vis Sci. 2004 Sep;45(9):3048-54. https://iovs.arvojournals.org/article.aspx?articleid=2163758 http://www.ncbi.nlm.nih.gov/pubmed/15326120?tool=bestpractice.com [63]White E, Walsh L. The impact of occlusion therapy and predictors on amblyopia dose-response relationship. Strabismus. 2022 Jun;30(2):78-89. http://www.ncbi.nlm.nih.gov/pubmed/35259060?tool=bestpractice.com
Daily treatment duration: 2 hours of daily patching was significantly superior to optical treatment alone in children with mild to severe strabismic and/or anisometropic amblyopia.[65]Wallace DK, Edwards AR, Cotter SA, et al. A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children. Ophthalmology. 2006 Jun;113(6):904-12. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1609192 http://www.ncbi.nlm.nih.gov/pubmed/16751033?tool=bestpractice.com
Dose intensity and overall treatment duration: one multicenter, randomized controlled trial reported that early intense patching (10 hours/day for 6 days/week) was more effective than extended optical treatment for shortening the treatment period, reducing the number of patching hours over time, and improving compliance.[57]Proudlock FA, Hisaund M, Maconachie G, et al. Extended optical treatment versus early patching with an intensive patching regimen in children with amblyopia in Europe (EuPatch): a multicentre, randomised controlled trial. Lancet. 2024 May 4;403(10438):1766-78. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02893-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/38704172?tool=bestpractice.com A faster treatment response may be seen in strabismic and/or severe amblyopia, in younger children, and during the first month of occlusive therapy.[63]White E, Walsh L. The impact of occlusion therapy and predictors on amblyopia dose-response relationship. Strabismus. 2022 Jun;30(2):78-89. http://www.ncbi.nlm.nih.gov/pubmed/35259060?tool=bestpractice.com
Compliance: patients are often noncompliant with patching due to adverse effects such as irritation, forced use of an eye with degraded vision, poor cosmesis, and lengthy treatment periods. Interventional materials may improve compliance in poorly adherent children and in children of non-native parents who speak the host country language poorly.[66]Tjiam AM, Holtslag G, Van Minderhout HM, et al. Randomised comparison of three tools for improving compliance with occlusion therapy: an educational cartoon story, a reward calendar, and an information leaflet for parents. Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):321-9. http://www.ncbi.nlm.nih.gov/pubmed/22820813?tool=bestpractice.com [67]Pradeep A, Proudlock FA, Awan M, et al. An educational intervention to improve adherence to high-dosage patching regimen for amblyopia: a randomised controlled trial. Br J Ophthalmol. 2014 Jul;98(7):865-70. http://www.ncbi.nlm.nih.gov/pubmed/24615684?tool=bestpractice.com Poor visual acuity at baseline has been associated with poor compliance.[60]Awan M, Proudlock FA, Gottlob I. A randomized controlled trial of unilateral strabismic and mixed amblyopia using occlusion dose monitors to record compliance. Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1435-9. https://iovs.arvojournals.org/article.aspx?articleid=2124546 http://www.ncbi.nlm.nih.gov/pubmed/15790912?tool=bestpractice.com
Atropine eye drops to blur the vision in the better eye (atropine or optical penalization therapy) are sometimes used as an alternative to patching. Patching and atropine penalization are equally effective, and visual benefits of treatment are maintained in the long term.[68]Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2002 Mar;120(3):268-78. http://www.ncbi.nlm.nih.gov/pubmed/11879129?tool=bestpractice.com [69]Repka MX, Kraker RT, Beck RW, et al. A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years. Arch Ophthalmol. 2008 Aug;126(8):1039-44. http://www.ncbi.nlm.nih.gov/pubmed/18695096?tool=bestpractice.com Atropine has been associated with better adherence and quality of life compared with patching, but with increased risk for adverse events.[70]Li T, Qureshi R, Taylor K. Conventional occlusion versus pharmacologic penalization for amblyopia. Cochrane Database Syst Rev. 2019 Aug 28;8(8):CD006460. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006460.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/31461545?tool=bestpractice.com
Children ages 3 to <7 years old with moderate amblyopia who were randomized to weekend atropine demonstrated an equivalent treatment response (improvement in visual acuity of the amblyopic eye from baseline to 4 months of 2.3 lines) to that of children receiving daily atropine.[71]Repka MX, Cotter SA, Beck RW, et al. A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology. 2004 Nov;111(11):2076-85. http://www.ncbi.nlm.nih.gov/pubmed/15522375?tool=bestpractice.com
Combined patching plus atropine penalization: some clinicians may intensify treatment by adding topical atropine to the daily patching regiment, but the literature suggests minimal to no added benefit with this approach.[77]Wang S, Wen W, Zhu W, et al. Effect of combined atropine and patching vs patching alone for treatment of severe amblyopia in children aged 3 to 12 years: a randomized clinical trial. JAMA Ophthalmol. 2021 Sep 1;139(9):990-6. https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2781899 http://www.ncbi.nlm.nih.gov/pubmed/34264296?tool=bestpractice.com [78]Pediatric Eye Disease Investigator Group (PEDIG) Writing Committee; Wallace DK, Kraker RT, Beck RW, et al. Randomized trial to evaluate combined patching and atropine for residual amblyopia. Arch Ophthalmol. 2011 Jul;129(7):960-2. https://pmc.ncbi.nlm.nih.gov/articles/PMC3156057 http://www.ncbi.nlm.nih.gov/pubmed/21746992?tool=bestpractice.com
Primary options
atropine ophthalmic: (1%) children ≥3 months of age: 1 drop into the nonamblyopic eye once daily; children ≥3 years: 1 drop into the nonamblyopic eye once daily, may repeat dose up to twice daily
More atropine ophthalmicDose regimens may vary (e.g., drops may be administered daily, on weekends only, or on 2 consecutive days each week). Consult your local guidelines or drug information source for more information.
management of strabismus
Treatment recommended for SOME patients in selected patient group
After the amblyopia has been treated, children with residual strabismus typically undergo strabismus surgery. See Strabismus.
optical correction
Often resolves with optical correction alone.[79]Wallace DK, Chandler DL, Beck RW, et al; Pediatric Eye Disease Investigator Group. Treatment of bilateral refractive amblyopia in children three to less than 10 years of age. Am J Ophthalmol. 2007 Oct;144(4):487-96. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2128700 http://www.ncbi.nlm.nih.gov/pubmed/17707330?tool=bestpractice.com
One prospective study evaluated the response to spectacle treatment for bilateral ametropic amblyopia in children ages 3-9 years.[79]Wallace DK, Chandler DL, Beck RW, et al; Pediatric Eye Disease Investigator Group. Treatment of bilateral refractive amblyopia in children three to less than 10 years of age. Am J Ophthalmol. 2007 Oct;144(4):487-96. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2128700 http://www.ncbi.nlm.nih.gov/pubmed/17707330?tool=bestpractice.com Mean binocular visual acuity improved from 20/63 at baseline to 20/25 at 1 year.
form-deprivation amblyopia
surgery
Early surgery is recommended when the cause of amblyopia is obstruction of the visual axis, such as corneal opacity, cataract, nonclearing vitreous hemorrhage, or severe ptosis.
Surgical intervention is less urgent when the form deprivation occurs bilaterally as opposed to unilaterally. To maximize visual outcomes, surgery for bilateral congenital cataracts should be performed before 14 weeks of age and earlier if possible, and surgery for unilateral congenital cataracts should be performed before 6 weeks of age.[80]Birch EE, Cheng C, Stager DR Jr, et al. The critical period for surgical treatment of dense congenital bilateral cataracts. J AAPOS. 2009 Feb;13(1):67-71. http://www.ncbi.nlm.nih.gov/pubmed/19084444?tool=bestpractice.com [81]Birch EE, Stager DR. The critical period for surgical treatment of dense congenital unilateral cataract. Invest Ophthalmol Vis Sci. 1996 Jul;37(8):1532-8. https://iovs.arvojournals.org/article.aspx?articleid=2161387 http://www.ncbi.nlm.nih.gov/pubmed/8675395?tool=bestpractice.com
patching
Treatment recommended for ALL patients in selected patient group
For patients with unilateral- or asymmetric-deprivation amblyopia, such as children with unilateral congenital cataracts, patching the sound eye is a necessary additional treatment.
optical correction of any refractive error ± patching or atropine
Treatment recommended for ALL patients in selected patient group
Deprivation amblyopia may coexist with other forms of amblyopia, including anisometropic and strabismic. These should be addressed in conjunction with treatment to clear the visual axis.
Ongoing treatment may be with correction of any refractive error with spectacles or contact lenses, with or without patching of the nonamblyopic eye or blurring of the nonamblyopic eye with atropine eye drops.
Primary options
atropine ophthalmic: (1%) children ≥3 months of age: 1 drop into the nonamblyopic eye once daily; children ≥3 years: 1 drop into the nonamblyopic eye once daily, may repeat dose up to twice daily
More atropine ophthalmicDose regimens may vary (e.g., drops may be administered daily, on weekends only, or on 2 consecutive days each week). Consult your local guidelines or drug information source for more information.
refractory amblyopia
temporary closure of better-seeing eye
Refractory amblyopia in a noncompliant patient can be treated by closing the eyelid over the better-seeing eye temporarily, using surgical or medical techniques. These include the use of sutures, injection of botulinum toxin to the levator muscle, and application of cyanoacrylate glue to the eyelid margin.[83]Arnold RW, Armitage MD, Limstrom SA. Sutured protective occluder for severe amblyopia. Arch Ophthalmol. 2008 Jul;126(7):891-5. http://www.ncbi.nlm.nih.gov/pubmed/18625933?tool=bestpractice.com [84]Hakim, OM, Gaber El-Hag Y, Samir A. Silicone-eyelid closure to improve vision in deeply amblyopic eyes. J Pediatr Ophthalmol Strabismus. 2010 May-Jun;47(3):157-62. http://www.ncbi.nlm.nih.gov/pubmed/20210278?tool=bestpractice.com Parents or caregivers might be hesitant to consent to these treatments given the need for anesthesia, as well as the cosmetic and psychological effects on the child.
Less invasive ways to improve compliance include the use of interventional materials, such as cartoons or information booklets. Randomized controlled trials have shown the benefit of using interventional materials to improve treatment compliance in poorly adherent children and in children of non-native parents who speak their host country language poorly.[66]Tjiam AM, Holtslag G, Van Minderhout HM, et al. Randomised comparison of three tools for improving compliance with occlusion therapy: an educational cartoon story, a reward calendar, and an information leaflet for parents. Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):321-9. http://www.ncbi.nlm.nih.gov/pubmed/22820813?tool=bestpractice.com [67]Pradeep A, Proudlock FA, Awan M, et al. An educational intervention to improve adherence to high-dosage patching regimen for amblyopia: a randomised controlled trial. Br J Ophthalmol. 2014 Jul;98(7):865-70. http://www.ncbi.nlm.nih.gov/pubmed/24615684?tool=bestpractice.com It is suggested that attempts should be made first with intervention material.
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer